Finance

Lists
IRON:NASDAQ
Disc Medicine Inc
$74.51
-2.61%
(-2.00) 1D
Sep 10, 1:17:22 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRON...
Open
$75.89
High
$76.59
Low
$73.81
Mkt. cap
2.86B
Avg. vol.
400.28K
Volume
198.50K
52-wk high
$99.50
52-wk low
$40.00
EPS
-$6.57
Beta
0.98
Shares outstanding
38.39M
No. of employees
165
Open
$75.89
High
$76.59
Low
$73.81
Mkt. cap
2.86B
Avg. vol.
400.28K
Volume
198.50K
52-wk high
$99.50
52-wk low
$40.00
EPS
-$6.57
Beta
0.98
Shares outstanding
38.39M
No. of employees
165
News stories
From web sources and news partners
About Disc Medicine Inc
CEO-
Employees165
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitediscmedicine.com
Analyst ratings
Based on 9 analysts giving stock ratings to IRON in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for IRON in the last 3 months.
Highest
Current $74.51
$125.00 (+67.76%)
Average
$104.86 (+40.73%)
Lowest
$88.00 (+18.10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$100.00
+34.2%
09/10/2026
Douglas Tsao
H.C. Wainwright
Buy
Maintained
$120.00
+61.1%
09/10/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$100.00
+34.2%
09/10/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$125.00
+67.8%
08/31/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
$90.00
+20.8%
08/17/2026
David Nierengarten
Wedbush
Buy
Maintained
$88.00
+18.1%
08/11/2026
Danielle Brill
Truist Financial
Buy
Maintained
-
-
08/11/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$111.00
+49%
07/31/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
07/30/2026
Evan Seigerman
BMO Capital
Buy
Maintained
$100.00
+34.2%
06/02/2026
Derek Archila
Wells Fargo
Buy
Maintained
$79.00
+6%
03/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
50.33M
45.37M
45.90M
46.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.36M
20.75M
23.62M
18.14M
Operating expense
67.70M
66.12M
69.52M
65.08M
Total operating expenses
67.70M
66.12M
69.52M
65.08M
Operating income
-67.70M
-66.12M
-69.52M
-65.08M
Other non operating income
-18.00K
-2.00K
22.00K
-12.00K
EBT including unusual items
-62.22M
-60.44M
-63.45M
-59.46M
EBT excluding unusual items
-62.22M
-59.59M
-63.45M
-59.46M
Income tax expense
102.00K
88.00K
51.00K
69.00K
Effective tax rate
-0.16%
-0.15%
-0.08%
-0.12%
Other operating expenses
-
-
-
-
Net income
-62.32M
-60.53M
-63.50M
-59.53M
Net profit margin
-
-
-
-
Earnings per share
-1.77
-1.62
-1.65
-1.54
Interest and investment income
6.41M
7.41M
6.89M
6.53M
Interest expense
-917.00K
-883.00K
-844.00K
-908.00K
Net interest expenses
5.50M
6.53M
6.05M
5.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
-67.61M
-66.03M
-69.44M
-64.98M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps